Efficacy and safety of incretin co agonists: Transformative advances in cardiometabolic healthcare It Is a Huge Market. The Pipeline Is Full. More GLP 1s Are On Their Way. Managed Healthcare Executive Semaglutide, a glucagon like peptide 1 (GLP 1) receptor agonist, has well established weight loss benefits. Cagrilintide, a long acting analogue of the satiety hormone amylin, has shown promise for weight loss in early trials. The potential benefit Effects of GLP 1 (blue arrows), glucagon (red arrows) and GIP (green Download Scientific Diagram Glucagon like Peptide 1, Glucose Dependent Insulinotropic Polypeptide, and Glucagon Receptor Agonists in Metabolic Dysfunction Associated Steatotic Liver Disease: Novel Medication in New Liver Disease Nomenclature